The formation of neurites is an important process affecting the cognitive abilities of an organism. Neurite growth requires the addition of new membranes, but the metabolic remodeling necessary to supply lipids for membrane expansion is poorly understood. Here, we show that synaptic activity, one of the most important inducers of neurite growth, transcriptionally regulates the expression of neuronal glucose transporter Glut3 and rate-limiting enzymes of glycolysis, resulting in enhanced glucose uptake and metabolism that is partly used for lipid synthesis. Mechanistically, CREB regulates the expression of Glut3 and Siah2, the latter and LDH activity promoting the normoxic stabilization of HIF-1α that regulates the expression of rate-limiting genes of glycolysis. The expression of dominant-negative HIF-1α or Glut3 knockdown blocks activity-dependent neurite growth in vitro while pharmacological inhibition of the glycolysis and specific ablation of HIF-1α in early postnatal mice impairs the neurite architecture. These results suggest that the manipulation of neuronal glucose metabolism could be used to treat some brain developmental disorders.
Introduction
Early postnatal brain development is characterized by the massive outgrowth of dendrites and axons (Wong & Ghosh, 2002) (Silbereis et al) . Among the different mechanisms affecting dendritic development, signaling from afferents is particularly important for dendritic growth (Groc et al, 2002; Konur & Ghosh; Rajan & Cline, 1998; Wong & Ghosh, 2002) . The most active phase of dendritic growth in the rat cerebral cortex is concurrent with the time of afferent innervations (Konur & Ghosh; Wong & Ghosh, 2002) . Moreover, blocking neuronal activity in vivo alters dendritic development (Groc et al, 2002; Rajan & Cline, 1998) , while increased neuronal activity by exposure to an enriched environment positively influences dendritic growth (Faherty et al, 2003) .
Activity-mediated calcium influx activates signaling events that influence dendritic architecture, modifiying cytoskeleton and activating transcriptional programs (Puram & Bonni, 2013; Wong & Ghosh, 2002) . Several transcription factors and co-activators have been described to promote dendritic growth (Puram & Bonni, 2013) , such as CREB, a transcription factor strongly activated by synaptic activity. In addition to its roles in cell survival and synaptic function, CREB is one of the most important transcription factors mediating activitydependent dendritic morphogenesis in mammalian brain neurons Puram & Bonni, 2013) .
Activation of CREB in cortical neurons induces dendritic growth and arborization, with dominant negative CREB suppressing activity-dependent neurite growth (Redmond et al) . Furthermore, CREB knockout mice show impaired axonal growth and projections (Lonze et al) . Despite the well-known function of CREB in regulating dendritic development, its target genes are not yet completely known.
Neurite growth requires cytoskeletal reorganization and cell membrane extension. The latter requiring a supply of lipids. Given the impermeable nature of the blood brain barrier (BBB) most plasma lipoproteins cannot cross the BBB and lipids need to be synthesized in the brain. Studies investigating the incorporation of radiolabeled glycerol into lipids and their transport indicate that the bulk of lipid synthesis occurs in the cell body of neurons, with the lipids then exported in vesicles to the axon and dendrites for membrane expansion (Goldberg, 2003; Pfenninger, 2009 ). However, little is known on where the precursors necessary for lipid synthesis come from. The intermediates of glycolysis serve as lipid precursors (Vander Heiden et al, 2009 ). Dihydroxyacetone phosphate (DHAP) is converted by glycerol-3-phosphate dehydrogenase 1 (GPD1) into glycerol-3-phosphate, which is then used for synthesizing glycerol-backbone lipids. Pyruvate, the end product of glycolysis, is transported to the mitochondria where it enters the tricarboxylic acid (TCA) cycle as citrate and is further metabolized or exported to the cytoplasm to be broken down by ATP-citrate lyase (ACLY) into oxaloacetate and acetyl-CoA, which serves as a precursor in lipid biosynthesis. Meta-analysis of brain and glucose consumption demonstrates that aerobic glycolysis increases in the human brain when synaptic growth rates are highest, suggesting that glycolysis provides biosynthetic support for neurite growth (Goyal et al, 2014) . However, it is unclear whether glycolysis is regulated by neuritogenic cues or is needed for neurite growth.
Hypoxia inducible factor 1 (HIF-1) is a transcription factor regulating adaptive responses to hypoxia. It occurs as heterodimer composed of an unstable HIF-1α and a stable HIF-1β (also known as ARNT). The heterodimer binds hypoxia response elements (HRE) on target genes, which includes those associated with glucose transport and glycolysis genes, among others (Denko, 2008; Semenza et al, 1994) . Normally, HIF-1α is ubiquitinated and degraded in normoxic conditions. Hydroxylation of Pro-402 and Pro-564 by prolyl hydroxylases (PHD) in the oxygen-dependent degradation domain (ODD) of human HIF-1α promotes interaction with the von Hippel-Lindau ubiquitin ligase complex (VHL) which targets HIF-1α for proteolysis (Ivan et al, 2001; Jaakkola et al, 2001; Maxwell et al, 1999) . Another regulatory element of the PHD/VHL pathway is the E3 ubiquitin ligase Siah2, which contributes to HIF-1α stabilization (Li et al, 2017; Nakayama et al, 2004) . Despite its generally short half-life in normoxia, HIF-1α can be stabilized in normoxia by growth factors, metabolite accumulation, the expression of oncogenes or ROS production (Denko, 2008) .
Although much is known on the molecular mechanisms mediating cytoskeletal remodeling and lipid transport to induce neurite growth, little is known about the metabolic adaptations required for neuronal membrane extension. Here, we show CREB activation by synaptic activity induces the expression of the glucose transporter Glut3 and promotes Siah2-mediated stabilization of HIF-1 that upregulates the expression of glycolysis genes. As a consequence, glucose metabolism is enhanced and part of it is used to provide the lipid precursors necessary for neurite growth.
Results

Glucose metabolism is necessary for activity-dependent neurite outgrowth
Neuronal activity promotes neurite growth which requires a supply of lipids to enlarge membranes. Accordingly, using an established method of network disinhibition to enhance synaptic activity by applying the GABAA receptor antagonist bicuculline (Bic) and the K + channel antagonist 4-aminopyridine (4AP) (Hardingham et al, 2001) , we observed that active neurons have increased levels of FASN and ACLY ( Fig. EV1A-C), two key enzymes for the novo lipid synthesis.
Glucose-derived acetyl-CoA is the main precursor for lipid biosynthesis (Divakaruni et al, 2017; Pietrocola et al, 2015) . Thus, it was analyzed incorporation of radioactively labeled glucose into lipids in neurons that have experienced an episode of synaptic activity. After 48 hours of stimulation, active neurons showed increased glucose incorporation into lipids (Fig. 1A) . This was impaired by knockdown of the glycolytic enzyme GPI (Fig. 1B and EV1D ). Glutamine metabolism is another major source of lipogenic acetyl-CoA (Pietrocola et al, 2015) , however synaptic activity did not increase glutamine incorporation into lipids (Fig EV1E) .
One molecule of glucose is converted to two molecules of pyruvate during glycolysis. Pyruvate enters the mitochondria, where it is decarboxylated to produce acetyl-CoA that then conjugates with oxaloacetate to produce citrate. Citrate can be further metabolized in the TCA cycle or exported to the cytoplasm, where it is converted into acetyl-CoA by ACLY to be used for fatty acid synthesis. Total and cytosolicic acetyl-CoA levels were also increased in active neurons ( Fig. 1C and D) , but not CoA levels (Fig EV1F) , which was not observed when glycolysis was inhibited with 2-deoxy-D-glucose (Fig 1E) , indicating a major role of glucose as a source of the increased amounts of acetyl-CoA. In agreement, knockdown of ACLY blocked activity-dependent enhanced glucose incorporation into lipids (Fig. 1F and EV1G and EV1H) .
In accordance with the need of glucose-derived lipid production to enlarge membranes for neurite growth, knockdown of Glut3 ( Fig. 1G and H) , the main glucose transporter in neurons, inhibition of glucose metabolism with 2-DG ( Fig. EV1I ), or knockdown of ACLY (Fig. EV1J ) abolished activity-mediated neurite growth which at this developmental stage represents axonal growth.
Synaptic activity stimulates neuronal glucose uptake and metabolism at the transcriptional level
To investigate whether increased acetyl-CoA levels correlated with increased glucose uptake and metabolism, neurons were stimulated for 24 hours with Bic+4AP, and washed for 30 minutes to allow restoration of ion gradients before analyzing glucose uptake. Bic+4AP washing effectively blocked burst firing ( Fig. EV2A and B) . It was found that neurons that had experienced synaptic activity increased their glucose uptake ( Fig. 2A and Fig. EV2C ). Glycolysis-produced pyruvate is partially metabolized into lactate in a reaction that regenerates NAD + that is necessary for glycolysis to continue. Glycolysis is the main source of lactate, accounting for 82-90% on different types of cells . Thus, lactate release into the medium is a commonly used surrogate of glycolytic flux (TeSlaa & Teitell, 2014) . Active neurons released 75% more lactate than resting ones (Fig. 2B) . This was not due to the hyperglycemic medium used in this study, since culturing the neurons with physiological glucose concentration in rat brain (2.4 mM; (Silver & Erecinska, 1994) ) produced similar lactate release (Fig. VE2D) . In another approach to demonstrate increased glycolysis in active neurons, neurons were stimulated for 24 hours and washed for 30 minutes, to allow restoration of ionic gradients, before uncoupling the mitochondria with CCCP for 30 minutes. This drastically reduced ATP levels, which were less reduced in the stimulated neurons than unstimulated ones, but only when glucose was present in the medium (Fig. 2C) , indicating that the increased glycolysis in active neurons can supply more ATP than in resting ones when the mitochondria are not functional.
Synaptic activity has been shown to mediate Glut3 translocation to the membrane (Ferreira et al, 2011) .
Moreover, synaptic activity is a potent regulator of gene expression programs (Bading, 2013; Greer & Greenberg, 2008) . Thus, we aimed to determine whether activity-mediated glycolysis induction was mediated at the transcriptional or posttranslational level. Cycloheximide was used to inhibite mRNA translation. If glucose metabolism induction was mainly due to posttranslational modifications, the increase in glucose metabolism would not be affected by cycloheximide treatment; it would be affected by cycloheximide if de novo protein synthesis was involved. We found that cycloheximide abolished the glucose metabolism induced by synaptic activity, which was established by measuring lactate release (Fig. 2B) . This was not consequence of reduced neuronal viability since cycloheximide treatment did not affect viability (Fig.   EV2E ). Next, we used qPCR to analyze the expression of Glut3, the main glucose transporter in neurons; HK2, PFK and PKM, the three regulating enzymes of the glycolysis; and PFKFB3, which produces fructose-2,6-bisphosphate, a potent allosteric activator of PFK. There was an increase in the expression of all these genes except PFK (Fig. 2D) . Strikingly, Glut3 showed a different expression pattern to these associated with glycolysis. Along with the increased mRNA levels, synaptic activity induced the protein expression of these genes ( Fig. 2E and F) . Interestingly, treatment of neurons with BDNF, a neurotrophic factor that induces neurite growth (Park & Poo, 2013) , also induced the expression of glucose metabolism genes, as well as increased glucose uptake and lactate release ( Fig. E2VF-H) , although it cannot be excluded an indirect effect due to BDNF-induced enhanced neuronal activity (Li et al, 1998) .
Glial and neuronal metabolism is coupled (Bélanger et al). Around 2% of our primary cortical neuron cultures were glial cells ( Fig. EV2I and J) . Neuronal glucose uptake experiments were analyzed by cell imaging, but the lactate release and ATP production experiments were performed using the mixed cultures. Thus, we could not rule out the possibility that activity-dependent enhanced glycolysis occurred in the glial cells rather than neurons. To clarify this, we used two approaches. The mitosis inhibitor AraC is used in our cortical cultures to block glial proliferation. In a first approach, we prepared parallel cortical cultures that were treated with AraC or not to obtain cultures with different proportions of glial cells ( Fig. EV2I and J) . If the stimulationmediated increase in lactate release was due to changes in gene expression in glial cells rather than neurons, modifying the abundance of glial cells in the co-culture would elicit a corresponding increase in lactate release after stimulation. Although cultures not treated with AraC had around tenfold more astrocytes than AraC treated ones, these two types of cultures showed the same degree of lactate release when stimulated, confirming that the enhanced glucose metabolism, and, consequently the expression of glucose metabolism genes when stimulated occurred in neurons rather than astrocytes (Fig. EV2K ). In the second approach, we used pure astrocyte cultures. Astrocytes express functional BDNF receptors (Ohira et al, 2005; Rose et al, 2003) , however BDNF did not increased lactate release in pure astrocyte cultures like it did in neuronal cultures ( Fig. EV2H and 2L) . Thus, enhancement of glucose metabolism takes place in neurons when stimulated with neurite growth inducers.
Activity-dependent induction of glycolysis genes depends on HIF-1a stabilization
Next we investigated the transcription factor responsible for the induction of activity-mediated glucose metabolism genes. HIF-1α is a transcription factor that stimulates glycolysis by transactivating the genes involved in intracellular glucose transport and glycolysis (Denko, 2008; Semenza et al, 1994) . Although HIF-1α is typically unstable in normoxia, certain conditions enable its stabilization in normoxic conditions (Denko, 2008) . Thus, HIF-1α could be responsible for inducing glucose metabolism genes. We observed HIF-1α stabilization in active and BDNF treated neurons (Figs. 3A, 3B , and EV3A-C), but not HIF-2α (Fig EV2E and F) , that correlated with increased HIF-1α transcriptional activation (Fig. 3C) . Overexpression of HIF-DN, a dominant negative form of HIF-1α (HIF-DN) formed by the DNA binding domain of HIF-1α and lacking the prolyl hydroxylase and transactivation regions, completely blocked activity-mediated transcriptional activation of HIF-1α (Fig. 3C ). Transduction with AAV-HIF-DN blocked activity-dependent induction of glycolysis genes, but had no effect on Glut3 gene expression ( Fig. 3D ). This was not completely surprising because the pattern of Glut3 expression was different to that of the glycolysis genes (Fig. 2D ). All together, these results indicate that the activity-dependent induction of glycolysis genes depends on HIF-1α
HIF-1α is stabilized by Siah2 and LDH activity
HIF-1α regulation is mainly mediated by proteosomal degradation in normoxia. Hydroxylation of prolynes in the ODD domain of HIF-1α by PHDs promotes HIF-1α proteolysis (Ivan et al, 2001; Jaakkola et al, 2001; Maxwell et al, 1999) . We studied whether synaptic activity decreased PHD activity. Neurons were transfected with a plasmid expressing firefly luciferase fused to the oxygen-dependent degradation domain of HIF-1α (ODD-Luc). Synaptic activity resulted in increased luciferase activity in ODD-Luc, but not wild type firefly luciferase (Luc) transfected neurons ( Fig. 4A and 4B ), indicating reduction in PHD activity. Siah2 is an E3 ubiquitin ligase that promotes HIF-1α stabilization mainly by mediating proteasomal degradation of PHDs (Nakayama et al, 2004) , although other mechanisms by which Siah2 promotes HIF-1α stabilization have been also described (Li et al, 2017 ). Siah2 mRNA and protein levels were induced by synaptic activity ( KD neurons showed a strong reduction of activity-dependent HIF-1α accumulation ( Fig. 4F-H and Fig EV4C- G). Next, we checked the expression levels of PHD in active neurons and surprisingly we observed no changes in PHD1, PHD3 and FIH, and increased expression of PHD2 (Fig EV4H and I ). One alternative mechanism by which Siah2 could HIF-1α is mediating degradation of the enzymes of the OGDHC, OGDH and DLST (Burr et al, 2016; Intlekofer et al, 2017; Nadtochiy et al, 2016; Sun & Denko, 2014 ) , but we could not observe changes in protein levels of these enzymes ( Fig. EV4H and I ). However, a central role of Siah2 upregulation in the activity-mediated enhanced glucose metabolism was further confirmed by showing that Siah2 KD blocked activity-mediated lactate release ( Fig 4I) and glucose incorporation into lipids (Fig. 4J ).
HIF-1α regulation is complex, with several regulators and mechanisms being involved. We tested whether other mechanisms different from the one mediated by Siah2 induction could participate as well in activitymediated HIF-1α stabilization. HIF-1α is anO 2 sensitive transcription factor that mediates the primary response to hypoxic stress. Excessive O 2 consumption in active neurons could generate transitory hypoxia that mediates HIF-1α stabilization. However, the use of a hypoxia sensor probe did not show hypoxia generation by synaptic activity (Fig. EV4J ). Despite synaptic activity regulates a transcriptional program of defense against oxidative stress , acute synaptic activity could boost mitochondrial metabolism and enhance ROS production which is involved in HIF-1α stabilization in normoxia, therefore we tested whether the use of antioxidants could block HIF-1α activation by synaptic activity, but it did not have any effect on activity-mediated HIF-1α stabilization (Fig EV4K and L) . Increased HIF-1α levels in active neurons were not due to the transcriptional regulation of HIF-1α either (Fig. EV4M ). Both rise in pyruvate and lactate levels stabilize HIF-1α (Lu et al, 2002) . We inhibited LDH with oxamate, which produces accumulation of pyruvate and reduces lactate release (Lu et al, 2002) . Oxamate treatment blocked activitymediated HIF-1α stabilization (Fig 4K and L) . Since, both, Siah2 KD and LDH inhibition almost completely blocked activity-mediated HIF-1α stabilization they may be part of the same regulatory pathway.
Glut3 and Siah2 expression is regulated by CREB
Since Glut3 expression in active neurons did not depend on HIF-1α activation, we explored which transcription factor could regulate it. CREB is a powerful regulator of synaptic activity-mediated gene expression (Bading, 2013; Greer & Greenberg, 2008) , controls neurite outgrowth (Redmond et al) and is involved in metabolic regulation in different cell types (Altarejos & Montminy, 2011) . CREB has been shown to regulate Glut3 expression (Rajakumar et al, 2004 ); thus, we tested whether CREB was involved in activitymediated Glut3 expression. Transduction of neurons with AAV expressing a dominant negative CREB (A-CREB; (Ahn et al, 1998)) blocked activity-dependent Glut3 expression (Fig. 5A ).
Given that Glut3 and Siah2 showed a similar pattern of mRNA expression following synaptic activity, a high activation after four hours with the decay at 24 hours ( Fig. 2D and 4C ), we assesed whether Siah2 was also regulated by CREB. A-CREB blocked Siah2 induction (Fig. 5C and D) and, consequently, blocked the HIF-1α stabilization induced by synaptic activity (Fig. 5C and E) . Furthermore, over-expression of the endogenous CREB inhibitor ICER (Molina et al, 1993 ) also blocked HIF-1α activity (Fig. 5F ) but did not disturb the activity of MEF2 (Fig EV5A) , an activity-dependent transcription factor (Greer & Greenberg, 2008) . Forskolin, adenylyl cyclase activator and hence CREB activator, was sufficient to induce Siah2 expression and HIF-1α stabilization and activation (Fig. 5G-J) . In agreement with an indirect CREB-dependent activation of HIF-1α via increased Siah2 expression, we observed that CREB activation preceded HIF-1α activation (Fig. 5K) .
As expected, A-CREB expression blocked activity-dependent lactate release (Fig. 5L ) and glucose incorporation into lipids (Fig. 5M) . Forskolin also stimulated lactate release (Fig. EV5B ) but had no effect on glucose incorporation into lipids (Fig. EV5C ), in agreement with the fact that cAMP greatly potentiates neuritic growth in response to neurotrophic factors but does not promote growth by its own (Goldberg et al, 2002) .
Defective glycolysis impairs neurite growth
This and the previous results suggest that Siah2 and HIF-1α may be necessary for neurite growth through regulating glycolysis. Indeed, HIF-1α or Siah2 over-expression in DIV 3 immature cortical neurons increased neurite length (Fig 6A-C ) that at this stage represents axonal growth (Dotti et al, 1988) . While HIF-DN expression or Siah2 knockdown blocked activity-dependent neurite growth in DIV 10 cortical neurons ( Fig. 
6D-G).
The first three weeks after birth is when maximum neurite growth occurs in mice, being synaptic activity one of the effectors of this growth (Wong & Ghosh, 2002) . In order to provide evidence about the in vivo role of glucose metabolism we administered PFKFB3 inhibitor 3PO (Schoors et al, 2014) for 5 days to rat pups that were 8 days old. Golgi staining showed reduced complexity of neuritic arbors in the cortex of 3PO administered rats (Fig. 6H-I ).
HIF-1α deletion in neural precursor cell progenitors leads to atrophy of the cerebral cortex, indicating an important role for HIF-1α in neuronal development in vivo (Tomita et al, 2003) . Thus, we compared HIF-1α expression in the brains of mice that were 10 days and 3 months old. We observed a higher density of HIF-1α positive cells and increased protein levels in 10 day-old mice compared to 3 month-old mice ( Fig. 6J and Fig. EV6A and B) . Expression of HIF-1α in 10 day-old mice brain was highest in cortex, hippocampus and corpus callosum (Fig. EV6C) . Dual staining reveled colocalization of HIF1α with the neuronal marker NeuN, and complete absence in astrocytes expressing GFAP (Fig. 6K) .
In order to provide evidence about the in vivo role of HIF-1α in neurite growth, we deleted HIF-1α in tamoxifen inducible HIF-1α KO mice that were 3-5 days old, when gross anatomy of the brain resembles to that of the adult but is characterized by outgrowth of dendrites and axons. Once these animals reached adulthood (4-6 months), the neuronal architecture of the cortex of WT and HIF-1α KO mice was analyzed by Golgi staining, which showed reduced complexity of neuritic arbors in the KO mice ( Fig. 6L and M) . Taken together, our results indicate that induction of glucose metabolism in neurons is required for proper neuronal development.
Discussion
Signaling from afferents plays an essential role in neurite growth (Groc et al, 2002; Rajan & Cline, 1998; Wong & Ghosh, 2002) . Here, we show that activity-dependent neurite growth requires induction of glucose metabolism. Synaptic activity enhances glucose uptake and metabolism, some of which is diverted towards lipid synthesis that is required for cell membrane enlargement during outgrowth. The induction of glucose metabolism is mediated at the transcriptional level, CREB induces Glut3 and Siah2, the latter promoting the normoxic stabilization of HIF-1α that regulates the expression of the rate-limiting enzymes involved in glycolysis (Fig. 7) .
Most of the glucose in the brain is oxidized to supply the large amounts of ATP required for maintaining membrane ion gradients and processes regulating to synaptic transmission (Harris et al; Magistretti & Allaman, 2015; Rangaraju et al). However, measurements of human brain glucose and oxygen consumption reveal that the total amount of glucose consumed is in excess of oxygen consumption (Goyal et al, 2014; Vaishnavi et al, 2010) . The utilization of aerobic glycolysis in the human brain differs across the developmental stages, with 35% of glucose being consumed aerobically after birth that falls to 10-12% in adulthood (Goyal et al, 2014) . This increased aerobic glycolysis during infancy correlates with the period of maximal neurite growth (Goyal et al, 2014; Silbereis et al, 2016) . Neuronal differentiation in vitro show increased expression levels of Glut3 and glycolysis enzymes, with 2-DG treatment of DIV1 cortical neurons blocking differentiation (Agostini et al, 2016) . These data agree with our findings that activity-dependent aerobic glycolysis is used to meet the biosynthetic requirements for neurite growth. Highly proliferative cancer cells rely on aerobic glycolysis, which it is known as the Warburg effect (Vander Heiden et al, 2009 ).
Despite aerobic glycolysis being a less efficient way of generating ATP it confers advantages to cancer cells such as the production of intermediates that support cell growth and division (Vander Heiden et al, 2009 ).
Although postmitotic neurons do not divide, they undergo massive growth during differentiation. A neurite with a diameter of 1 µm elongating 0.55 µm per day must expand its surface at a rate of around 1µm 2 per minute to reach 250,000 µm 2 which is the typical neuron surface area, compared with 1,256 µm 2 membrane surface of a spherical cell with 20 µm diameter (Pfenninger, 2009 ).
Astrocytes and neurons are metabolically coupled. The astrocyte-neuron lactate shuttle (ANLS) hypothesis
proposes that the lactate produced by astrocytes is released and taken up by neurons to produce energy (Pellerin & Magistretti, 1994) . Although there is a lot of evidence supporting the ANLS there are also data that oppose this hypothesis (Dienel, 2017; Lundgaard et al, 2015; Patel et al, 2014; Pellerin & Magistretti, 2012) . Here, we clearly demonstrate that synaptic activity boosts glucose uptake and metabolism in neurons, rather than glial cells, by upregulating Glut3 and glycolysis genes. Increasing the proportion of glial cells in our primary cultures did not result in increased lactate release after stimulation, neither BDNF treatment affected lactate release in astrocytes unlike the stimulatory effect in lactate release in neuronal cultures.
Moreover, glucose uptake in neurons was observed by live-imaging, and HIF-1α activation measured with luciferase reporters is based in neuronal-specific transfection protocol which nearly the totality of transfected cells are neurons . In accordance with our results, a very recent study (BasOrth et al, 2017) showed synaptic activity caused an up-regulation of glycolytic genes with the subsequent increase in glycolytic metabolism. Isolating neurons by FACS allowed the authors to conclude that the induction of glycolytic genes was produced in neurons. Despite strong evidence indicating that glucose metabolism is activated by synaptic activity in neurons, these results do not oppose the ANLS, but supports the notion that neurons take up and metabolize through glycolysis in certain conditions (Ashrafi et al, 2017; Díaz-García et al, 2017; Jang et al; Lundgaard et al, 2015; Zala et al) . Cell division, migration and neurite growth require extraordinary levels of energy that would explain why the supply of energy in neurons is not limited to the astrocytic lactate during pre-and postnatal stages. This is also seen in the support of cholesterol synthesis in neurons by astrocytes, which can supply sufficient levels of cholesterol to adult neurons unable to synthesize cholesterol, but cannot do so during the phase of maximal membrane growth (Fünfschilling et al, 2012) .
Activity-mediated CREB activation plays a pivotal role in enhanced glucose metabolism. In neurons, CREB is a key transcription factor that regulates plasticity, cell survival and neurite growth (Bading, 2013; Greer & Greenberg; Redmond et al, 2002) . In peripheral tissues, CREB has a major metabolic role, regulating glucose and lipid metabolism in insulin-sensitive tissues (Altarejos & Montminy, 2011). As previously described (Rajakumar et al, 2004) , we observed CREB-mediated regulation of Glut3 gene expression, the main glucose transporter in neurons. In addition, CREB promoted Siah2 gene expression and, consequently, HIF-1α stabilization, which resulted in the increased gene expression of the rate-limiting enzymes involved in glycolysis. HIF-1α is best known as a transcription factor that mediates adaptation to hypoxia. Genes associated with glucose metabolism are the largest functional group regulated by HIF-1α (Denko, 2008; Semenza et al, 1994) . HIF-1α KO leads to embryonic lethality at E11, producing cardiovascular and brain malformations (Iyer et al, 1998; Ryan et al, 1998) . HIF-1α deletion in neuronal progenitors elicits cerebral cortex atrophy, defective brain development with fewer neural cells and impaired of spatial memory (Tomita et al, 2003) however HIF-1α deletion in mature neurons using CaMKII-CRE does not generate any evident major morphological defect (Helton et al, 2005) . Here, we show that HIF-1α deletion in early postnatal mice, a period of maximal afferent innervations and neurite growth, disturbs neurite architecture in the adult.
HIF-1α activation is regulated at multiple levels. We observed that synaptic activity reduced PHD activity, while CREB upregulated the expression of the ubiquitin ligase Siah2, and that activity-dependent induction of Siah2 is necessary for stabilizing HIF-1α. Siah2 KO mice exhibit mild phenotypes and do not show obvious brain abnormalities (Frew et al, 2003) . However, the presence of other Siah proteins (1a and 1b) may explain this lack of phenotype, given that double Siah1a/2 KO animals show a more severe phenotype regarding HIF-1α activity than Siah2 KO mice (Nakayama et al, 2004 ). The first mechanism described by which Siah1 and 2 proteins stabilize HIF-1α was by promoting proteasomal degradation of PHDs (Nakayama et al, 2004 ).
However, we could not detect reduction in PHDs after synaptic activity. HIF-1α is known to interact with more than one hundred proteins (Semenza, 2017) , most of them regulating HIF-1α stability. Among the interacting proteins some of them have been shown to be targeted by Siah2, such as Polo-like kinase 3 (PLK3) that phosphorylates and destabilizes HIF-1α (Xu et al, 2010) , and Siah2-mediated PLK3 degradation results in HIF-1α activation (Li et al, 2017) . Sprouty2 promotes HIF-1α ubiquitination (Hicks & Patel, 2016) , is regulated by Siah2 (Qi et al, 2008) and its downregulation promote axonal growth (Hausott et al, 2009; Hausott et al, 2012; Marvaldi et al, 2015) , however the link between these three observations have not been established. We observed that both Siah2 knockdown or LDH inhibition almost completely blocked activity- ). Siah2 has been reported to disrupt OGDHC complex Sun & Denko, 2014 ) but acute synaptic activity did not affect protein levels of OGDHC. Future studies will be aimed to understand the interrelationship between Siah2 and LDH to promote activity-mediated HIF-1α stabilization.
Disruption of dendritic development is the most consistent anatomical finding in mental retardation (Kaufmann & Moser, 2000) . The role of abnormal cytoskeletal remodeling has been associated with mental retardation in some syndromes but further studies are required to determine how glucose metabolism is affected. Glut1 deficiency syndrome or chronic hypoglycemia (congenital or early infantile) causes the syndrome of glycopenia which is characterized by seizures, developmental delay and mental retardation (Pascual et al, 2007) . Here, we have showed that activity-mediated neurite growth requires enhanced glucose metabolism to supply lipids for membrane enlargement. Further studies are required to determine how glucose metabolism is affected in intellectual development disorders. Those studies could lead to the possibility of manipulating glucose metabolism to treat of some forms of intellectual development disorders.
Cell culture and stimulation
Cortical neurons from E21 Sprague Dawley rats were cultured as described previously . See supplementary information.
HIF-1α gene inactivation in vivo
To study the in vivo role of HIF-1α in neuronal architecture, we used previously described HIF1α floxed UBC-CRE-ERT2 mice (Soro-Arnaiz et al, 2016). These mice ubiquitously express a tamoxifen-inducible CRE recombinase (cre-ERT2) that allows global inactivation of HIF-1α locus flanked by two LoxP sites upon 4OH-tamoxifen treatment. For HIF-1α gene inactivation, the newborn mice received tamoxifen via breast feeding from the mother. Weaning mothers were injected intraperitoneally with 4OH-tamoxifen daily for 5 days (2 mg/day) starting 3-5 days postpartum. After this period females were returned to a standard mouse diet.
Once newborns reached adulthood (4-6 months) neuronal architecture was analyzed. Mice were kept under specific pathogen-free conditions at the animal facility at the Autonomous University of Madrid (UAM).
3PO administration
See supplementary information
Histology
See supplementary information
Transfection, plasmids and virus generation
Neurons were transfected at DIV8 using Lipofectamine 2000 (Invitrogen). Transfection efficiency was approximately 5 % which nearly the totality of transfected cells are neurons .
Neurons were infected with rAAV at DIV4. Infection efficiencies were determined at DIV 10-11 by analyzing GFP fluorescence or immunocytochemical analysis and were observed to range from 70 to 85% of the viable neurons. See supplementary information
Neurite length measurement
Cortical neurons were transfected with a plasmid expressing GFP and neurons were fixed 48 hours later with 4% paraformaldehyde, permeabilized, blocked and incubated over-night at 4°C with anti-GFP antibody
(1:750, A11122, Life Technologies). Antibody binding was visualized using a biotinylated secondary antibody Preparations were mounted on VECTASHIELD Mounting Medium with DAPI (Vector Laboratories).
Images were taken blindly at 4X magnification using an Olympus BX61 microscope equipped with an Olympus DP70 camera. Neurites were manually traced and analyzed using Simple Neurite Tracer software (Longair et al, 2011) .
Luciferase assays
Cells were transfected with firefly luciferase-based reporter plasmid along with a Renilla expressing vector (pTK-RL; Promega), together with, where relevant, an HIF-DN or A-CREB expression vector. Luciferase assays were performed using the Dual Glo Luciferase Assay system (Promega) with firefly luciferase-based reporter gene activity normalized to the Renilla control (pTK-RL plasmid), except the CMV-ODD-Luc and CMV-Luc experiments that were normalized to CMV-Renilla.
RNA isolation, RT-PCR and qPCR
RNA was isolated using an PureLink TM RNA mini kit (Life Technologies 
Western blotting and antibodies
See supplementary information
Acetyl-CoA and CoA determination
Acetyl-CoA and CoA levels were measured using the Acetyl-Coenzyme A and CoA Assay Kits, respectively (Sigma). See supplementary information.
Glucose uptake measurements
The uptake of 2-[N-(7-nitrobenze-2-oxa-1, 3 diazol-4-yl) amino]-2 deoxy-glucose (2-NBDG, Life Technologies), a fluorescent glucose analog, was used to measure glucose transport. Cortical neurons were rinsed 3 times with phenol-red free SGG medium with reduced glucose concentration (0.5 mM) and incubated with 100 µM 2-NBDG in reduced glucose SGG medium for 30 minutes at 37ºC and 5% CO 2 . Cultures were washed three times with phenol-red free SGG medium to remove free 2-NBDG. Accumulation of intracellular 2-NBDG, measured using an excitation wavelength of 488 nm, was imaged under a Leica DMIRB microscope equipped with a Leica DFC 550 camera at 40× magnification. ROIs of the same surface were drawn in the soma and fluorescence intensity was analyzed using ImageJ (Schneider et al, 2012) .
Imaging studies
Neurons were visualized using a TCS SP2 Leica confocal laser scanning microscope (Leica Lasertechnick GmbH, Mannheim, Germany) adapted to an inverted Leitz DMIRBE microscope at 37°C in a controlled 5%
CO2 atmosphere (Life Imaging Services). Pictures were acquired using a 40× (1.25-0.75 NA) Leitz PlanApochromatic objective. Images were analyzed using ImageJ software.
Cytoplasmic Ca 2+ was monitored with Fluo-4 (Life Technologies). Neurons were loaded 2 μM Fluo-4 for 45 min at room temperature in phenol-red free SGG medium with 10mM HEPES and 10mM glucose. After 3 washes with phenol-red free SGG medium, neurons were de-esterified for 30 min at room temperature, excited at 488 nm and emission captured with a 516-nm filter.
For hypoxia analysis, neurons were loaded with 10 µM Image-IT Hypoxia Reagent (Life Technologies) in HBSS medium, and placed in an incubator chamber attached to the microscope, which was flushed with 95% N2/5% CO2 at a flow rate of 20 l/min at 37°C for 30min. Non-hypoxic neurons were maintained in normoxic conditions during probe incubation. Neurons were excited at 490 nm, and emission was measured using a 610-nm filter.
Lactate measurement
The culture medium was filtered using 10K Amicon Ultra-0.5 mL centrifugal filters (EMD Millipore). Then, 50
µL of medium was incubated with 200 µL of reaction buffer (320 mM glycine, 320 mM hydrazine, 2.4 mM NAD + and 2 U/mL of lactate dehydrogenase (LDH). After 30 minutes of incubation at room temperature, the lactate-dependent generation of NADH was measured at 340 nm using the Infinite 200 PRO multimode reader (Tecan). Lactate levels were normalized by total protein levels, quantified using Pierce BCA Protein Assay Kit (Thermo Scientific).
Glucose and glutamine incorporation into lipids
Neurons were grown on glass coverslips for 48 hours in a medium containing 0.8 µCi/ml 14 C-U-glucose (Perkin-Elmer) or 2 µCi/ml L-3-4-ATP levels were measured using the ATPlite Luminescence Assay System (Perkin-Elmer) on the Infinite 200 PRO multimode reader (TECAN) following the manufacteurer's instructions. ATP levels were normalized by total protein levels, quantified using Pierce BCA Protein Assay Kit (Thermo Scientific).
Statistical analysis
Statistical analysis involved two-tailed Student's t-tests. For any multiple comparisons within data sets, we used a one-way ANOVA followed by Tukey's post-hoc test. All data are presented as the mean ± s.e.m. of at least three independent experiments (n). A p value less than 0.05 was considered statistically significant.
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The authors declare that they have no conflict of interest. C-U-glucose were stimulated with bicuculline plus 4-AP (labeled Bic in this and subsequent figures) for 48 hours or left unstimulated (CT). Cellular lipids were extracted and radioactive counts measured (n= 4-7 independent experiments). Values represent mean ± s.e.m. *p<0.05, two-tailed Student's t-test (A) and ANOVA one-way ANOVA followed by Tukey's post-hoc test (B). C) Cortical neurons were stimulated for 24 hours with Bic+4-AP in the presence of glucose (n= 8 independent experiments). After 24 hours total acetyl-CoA levels were assayed. Values represent mean ± s.e.m. *p<0.05, two-tailed Student's t-test. D) Determination of cytosolic acetyl-CoA levels after 24 hours of Bic+4-AP stimulation in the presence of glucose (n= 4 independent experiments). Values represent mean ± s.e.m. *p<0.05, two-tailed Student's t-test. E) Acetyl-CoA levels in cortical neurons stimulated for 24 hours with Bic+4-AP in the presence of 25 mM of the non-metabolizable glucose analog 2-DG (n= 4 independent experiments). F) 14 C-U-glucose incorporation into lipids in neurons transduced with AAV expressing shRNAsc or targeting ACLY (sh-ACLY) after 48 hours stimulation with Bic+4-AP. (n=7 independent experiments). Values represent mean ± s.e.m. *p<0.05, one-way ANOVA followed by Tukey post-hoc test. G and H) Neurite length and representative tracings of the neuritic tree of control and Bic+4-AP stimulated neurons (for 48 hours) after transfection with non-targeting (siC) or Glut3-targeting (siGlut3) siRNAs (n= 45-49 neurons from 9 independent experiments). Scale bar, 500 µm. Values represent mean ± s.e.m. *p<0.05, one-way ANOVA followed by Tukey's post-hoc test. A) 2-NBDG uptake over 15 minutes in control or Bic+4-AP stimulated (for 24 h) neurons after washing and medium replacement (n= 4 independent experiments). Values represent mean ± s.e.m. *p<0.05, two-tailed Student's t-test. B) Neurons treated or not with cycloheximide (10 µM) were stimulated with Bic+4-AP (for 24 h) before measuring the amount of lactate released into the medium (n= 4-7 independent experiments). Values represent mean ± s.e.m. *p<0.05, two-tailed Student's t-test. C) ATP levels in unstimulated neurons that were treated with CCCP (3 nM) following the indicated chronogram. + or -glucose indicates whether the fresh medium added after the wash step contained glucose or not. (n= 3-6 independent experiments). Values represent mean ± s.e.m. *p<0.05, two-tailed Student's t-test. D) Cortical neurons were stimulated with Bic+4-AP for 4 or 24 hours and mRNA expression of the indicated genes was determined by real-time qPCR (n= 3-6 independent experiments). Values represent mean ± s.e.m. *p<0.05, two-tailed Student's ttest. E) Representative western blot and (F) densitometric analysis of protein samples from control and Bic+4-AP-stimulated (24 hours) (n= 3-4 independent experiments). (1) induces Ca 2+ transients (2) that activate the transcription factor CREB (3). CREB upregulates Glut3 expression to increase glucose uptake by neurons. CREB also increases Siah2 expression that together with LDH activity promote the stabilization and activation HIF-1α (4, 5), which in turn activates the expression of genes encoding the rate-limiting enzymes of glycolysis. B) Transcriptional changes induced by synaptic activity increase glucose uptake and enhance glycolytic flux. As a result, metabolites such as acetyl-CoA are generated and used for lipid synthesis necessary for membrane extension during neurite growth. Some graphics in the figure were obtained and modified from Smart Servier Medical Art (https://smart.servier.com/). 
